UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 224

Sortiert nach

KRAS mutation: from undruggable to druggable in cancer

Signal transduction and targeted therapy, 2021-11, Vol.6 (1), p.386-20, Article 386

2021

Volltextzugriff (PDF)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors

Acta pharmaceutica Sinica. B, 2015-09, Vol.5 (5), p.390-401

2015

Volltextzugriff (PDF)

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

Molecular cancer, 2018-02, Vol.17 (1), p.25-25, Article 25

2018

Volltextzugriff (PDF)

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance

Journal of hematology and oncology, 2022-12, Vol.15 (1), p.173-173, Article 173

2022

Volltextzugriff (PDF)

Targeting calcium signaling in cancer therapy

Acta pharmaceutica Sinica. B, 2017-01, Vol.7 (1), p.3-17

2017

Volltextzugriff (PDF)

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

Acta pharmaceutica Sinica. B, 2021-06, Vol.11 (6), p.1400-1411

2021

Volltextzugriff (PDF)

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

Molecular cancer, 2020-05, Vol.19 (1), p.81-81, Article 81

2020

Volltextzugriff (PDF)

Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance

Molecular cancer, 2020-03, Vol.19 (1), p.58-58, Article 58

2020

Volltextzugriff (PDF)

The key roles of cancer stem cell-derived extracellular vesicles

Signal transduction and targeted therapy, 2021-03, Vol.6 (1), p.109-15, Article 109

2021

Volltextzugriff (PDF)

Clinical significance of FBXW7 loss of function in human cancers

Molecular cancer, 2022-03, Vol.21 (1), p.87-87, Article 87

2022

Volltextzugriff (PDF)

CD39/CD73/A2AR pathway and cancer immunotherapy

Molecular cancer, 2023-03, Vol.22 (1), p.44-44, Article 44

2023

Volltextzugriff (PDF)

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response

Oncotarget, 2016-05, Vol.7 (20), p.29794-29803

2016

Volltextzugriff (PDF)

Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy

Nature communications, 2017-11, Vol.8 (1), p.1777-11, Article 1777

2017

Volltextzugriff (PDF)

The strategies to cure cancer patients by eradicating cancer stem-like cells

Molecular cancer, 2023-10, Vol.22 (1), p.1-171, Article 171

2023

Volltextzugriff (PDF)

Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer

Molecular cancer, 2021-01, Vol.20 (1), p.17-17, Article 17

2021

Volltextzugriff (PDF)

Editor Profile:Guest Editor of Special Issue on Targets and Anticancer Drug Research

Acta pharmaceutica Sinica. B, 2017, Vol.7 (1), p.1-1

Fu, Liwu

2017

Volltextzugriff (PDF)

Editorial for targets and anticancer drug research

Acta pharmaceutica Sinica. B, 2017, Vol.7 (1), p.2-2

Fu, Liwu

2017

Volltextzugriff (PDF)

Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance

Molecular cancer, 2019-12, Vol.18 (1), p.182-182, Article 182

2019

Volltextzugriff (PDF)

Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure

Signal transduction and targeted therapy, 2022-03, Vol.7 (1), p.89-89, Article 89

2022

Volltextzugriff (PDF)

Author Correction: ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics

Scientific reports, 2020-07, Vol.10 (1), p.12467-12467, Article 12467

2020

Volltextzugriff (PDF)

Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo

Biochemical pharmacology, 2017-01, Vol.124, p.29-42

2017

Volltextzugriff (PDF)

Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells

Molecular cancer, 2020-09, Vol.19 (1), p.139-139, Article 139

2020

Volltextzugriff (PDF)

14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2

Molecular cancer research, 2017-04, Vol.15 (4), p.418-428

2017

Volltextzugriff (PDF)

Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (42), p.E4504-E4512

2014

Volltextzugriff (PDF)

Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer

Signal transduction and targeted therapy, 2020-08, Vol.5 (1), p.141-141, Article 141

2020

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(132)
Humans
(71)
Oncology
(45)
Animals
(37)
Physical Sciences
(37)
Cell Line, Tumor
(32)
Pharmacology & Pharmacy
(30)
Environmental Sciences
(29)
Environmental Sciences & Ecology
(29)
Cancer
(28)
Antineoplastic Agents - Pharmacology
(25)
Multidrug Resistance
(25)
Mice
(24)
Chemistry
(23)
Female
(22)
Cell Biology
(21)
Tumors
(21)
Chemotherapy
(20)
Biochemistry & Molecular Biology
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

KRAS mutation: from undruggable to druggable in cancer

Mechanisms of resistance to EGFR tyrosine kinase inhibitors

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance

Targeting calcium signaling in cancer therapy

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy

Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance

The key roles of cancer stem cell-derived extracellular vesicles

Clinical significance of FBXW7 loss of function in human cancers

CD39/CD73/A2AR pathway and cancer immunotherapy

The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response

Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy

The strategies to cure cancer patients by eradicating cancer stem-like cells

Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer

Editor Profile:Guest Editor of Special Issue on Targets and Anticancer Drug Research

Editorial for targets and anticancer drug research

Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance

Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure

Author Correction: ABCG2-overexpressing H460/MX20 cell xenografts in athymic nude mice maintained original biochemical and cytological characteristics

Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo

Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells

14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2

Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers

Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer

Suchergebnisse filtern